Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4

American Journal of Pathology

Volumn 150, Issue 2, 1997, Pages 437-443

  Montine, Kathleen S ^a   Oison, Sandra J ^a   Amarnath, Ventkataraman ^a   Whetsell Jr , William O ^a   Graham, Doyle G ^a   Montine, Thomas J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; APOLIPOPROTEIN E4; CYTOSKELETON PROTEIN; PYRROLE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHERITANCE; LIPID PEROXIDATION; MALE; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; PYRAMIDAL NERVE CELL; RISK FACTOR; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALDEHYDES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PYRROLES; PYRROLIDINES; TISSUE DISTRIBUTION;

EID: 0031028437     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Smith CD, Carney JM, PE Reed-Starke, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc Natl Acad Sci USA 1991, 88:10540-10543
2. Stadtman ER: Protein oxidation and aging, Science 1992, 257:1220-1224
3. Mecocci P, MacGarvey U, Kaufman AE, Koontz D, JM Shoffner, Wallace JM, Beal MF: Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 1993, 34:609-616
4. Harman D: Free radical theory of aging: role of free radicals in the orientation and evolution of life, aging, and disease processes. Free Radicals, Aging, and Degenerative Diseases. Edited by JE Johnson, R Walford, D Harmon, J Miguel. New York, Alan R Liss, 1986, pp 3-49
5. Ames BN, Shigenaga MK: Oxidants are a major contributor to aging. Aging and Cellular Defense Mechanisms. Edited by C Franceschi, VJ Cristofalo, J Vijg. New York, NY Acad Sci, 1992, pp 85-95
6. Subbarao KV, Richardson JS, Ang LC: Autopsy samples of Alzheimer's cortex show increased peroxidation In vitro. J Neurochem 1990, 55:342-345
7. Peterson C, Goldman JE: Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc Natl Acad Sci USA 1986, 83:2758-2762
8. Pappolla MA, Omar RA, Kim KS, Robakis NK: Immunohistochemical evidence of antioxidant stress in Alzheimer's disease. Am J Pathol 1992, 140:621-628
9. Martins RN, Harper CG, Stokes GB, Masters CL: Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 1986, 46:1042-1045
10. Mecocci P, MacGarvey U, Beal MF: Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994, 36:747-751
11. Lovell M, Ehmann W, Butler S, Markesbery W: Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45:1594-1601
12. Gsell W, Conrad R, Hickethier M, Sofie E, Frolich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P: Decreased catalase activity but unchanged Superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J Neurochem 1995, 64:1216-1223
13. Gotz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K, Hebenstreit G, Frolich L, Beckmann H, Riederer P: Susceptibility of brains from patients with Alzheimer's disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 1992, 3:213-222
14. Furuta A, Price DL, Pardo CA, Troncoso JC, Xu ZS, N Taniguchi, Martin LJ: Localization of Superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 1995, 146: 357-367
15. Smith M, Sayre L, Monnier V, Perry G: Radical AGEing in Alzheimer's disease. Trends Neurosci 1995, 18:172-176
16. Farber JL: Mechanisms of cell injury. Pathology of Environmental and Occupational Disease. Edited by JE Craighead. St Louis, Mosby-Year Book, 1995, pp 287-302
17. Uchida K, Stadtman ER: Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1993, 268:6388-6393
18. Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG: E-4-Hydroxy-2-nonenal is cytotoxic and crosslinks cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 1996, 148:89-93
19. Ledesma MD, Bonay P, Colaco C, Avila J: Analyses of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994, 269:21614-21619
20. Van SD, Chen X, Schmidt AM, Brett J, Godman G, Zou YS, Scott CW, Caputo C, Frappier T, Smith MA: Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidative stress. Proc Natl Acad Sci USA 1994, 91:7787-7791
21. Good PF, Werner P, Hsu A, Olanow CW, Perl DP: Evidence for neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996, 149:21-28
22. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N: Oxidative damage in Alzheimer's. Nature 1996, 382:120-121
23. Esterbauer H, Schaur RJ, Zollner H: Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radical Biol Med 1991, 11:81-128
24. Friguet B, Stadtman ER, Szweda LI: Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 1994, 269:21639-21643
25. Szweda LI, Uchida K, Tsai L, Stadtman ER: Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. J Biol Chem 1992, 268:3342-3347
26. Uchida K, Stadtman E: Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal. Proc Natl Acad Sci USA 1992, 89:5611-5615
27. Sayre LM, Arora PK, Iyer RS, Salomon RG: Pyrrole formation from 4-hydroxynonenal and primary amines, Chem Res Toxicol 1993, 6:19-22
28. Graham DG, Amarnath V, Valentine WM, Pyle SJ, Anthony DC: Pathogenetic studies of hexane and carbon disulfide neurotoxicity. Crit Rev Toxicol 1995, 25(2):91-112
29. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer's disease. Proc Natl Acad Sci USA 1995, 92: 4725-4727
30. Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong LM, Jakes R, Alberts MJ, Gilbert JR, Man S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD: Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994, 125(2):163-171
31. Mahley R, Nathan B, Bellosta S, Pitas R: Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr Opin Lipidol 1995, 6(2):86-91
32. Castano E, Prelli F, Wisniewski T, Golabek A, Kumar R, Soto C, Frangione B: Fibrillogenesis in Alzheimer's dis- ease of amyloid β peptides and apolipoprotein E. BioChem J 1995, 306:599-604
33. Matthews R, Beal M: Increased 3-nitrotyrosine in brains of apoE-deficient mice. Brain Res 1997 (in press)
34. Hayek T, Oiknine J, Brook JG, Aviram M: Increased plasma and lipoprotein flpid peroxidation in apoE-deficient mice. Biochem Biophys Res Commun 1994, 210:1567-1574
35. Gardner HW, Bartelt RJ, Weisleder D: A facile synthesis of 4-hydroxy-2(E)-nonenal. Lipids 1992, 27:686-689
36. Amarnath V, Amarnath K, Valentine WM, Eng MA, Graham DG: Intermediates in the Paal-Knorr synthesis of pyrroles: 4-oxoaldehydes. Chem Res Toxicol 1995, 8:234-238
37. Montine TJ, Huang DY, Valentine WM, Amarnath V, Saunders A, Weisgraber KH, Graham DG, Strittmatter WJ: Crosslinking of apolipoprotein E by products of lipld peroxidation. J Neuropathol Exp Neurol 1996, 55: 202-210
38. Montine TJ, Farris DB, Graham DG: Covalent crosslinking of neurofilament proteins by oxidized catechols as a potential mechanism of Lewy body formation. J Neuropathol Exp Neurol 1995, 54:311-319
39. Khachaturian ZS: Diagnosis of Alzheimer's disease, Arch Neurol 1985, 42:1097-1105
40. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, Vogel FS, Hughes JP, vanBelle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486
41. Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper MD, Alberts MJ: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43: 1467-1472
42. Jirousek M, Murthi K, Salomon R: Electrophilic levuglandin E2-protein adducts bind glycine: a model for protein crosslinking. Prostaglandins 1990, 40:187-203
43. Selkoe DJ, Ihara Y, Salazar FJ: Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 1982, 215:1243-1245
44. Blass JP: Pathophysiology of the Alzheimer's syndgrome. Neurology 1993, 43:S25-S38
45. Roses A: On the metabolism of apolipoprotein E and the Alzheimer diseases. Exp Neurol 1995, 132:149-156
46. Roses AD: Apolipoprotein E is a relevant susceptibility gene that affects the rate of expression of Alzheimer's disease. Neurobiol Aging 1994, 15:5165-5167
47. Breitner JC, Welsh KA, Gau BA, McDonald WM, Steffens DC, Saunders AM, Magruder KM, Helms MJ, Plassman BL, Folstein MF: Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995, 52:763-771